LSU Pennington Biomedical’s Jeffrey Keller at Aging2.0 Launch

Tuesday, September 18, 2018
6:00pm - 8:30pm

Top dementia scientist Dr. Jeffry Keller will discuss how innovative uses of technology could help overcome the current limitations in geriatric and dementia research during the launch of Aging2.0’s Baton Rouge chapter, set for 6-8:30 p.m. Tuesday, Sept. 18, at LSU Pennington Biomedical Research Center. Keller, director of Pennington Biomedical’s Institute for Dementia Research and Prevention, focuses his research on dementia, Alzheimer’s disease and the elderly population through numerous clinical trials. He has extensive knowledge and experience in developing technologies that benefit the elderly, and Pennington Biomedical has successfully licensed those technologies. Pennington Biomedical provides space for companies in the Pennington Biomedical BioTech Initiative, a joint venture between the research center and LSU’s Louisiana Business and Technology Center. The BioTech Initiative promotes economic development and research commercialization. Keller plans to talk about potential solutions using technology to overcome those obstacles, including work underway at Pennington Biomedical. He is one of five speakers scheduled for Aging2.0.

LSU Pennington Biomedical’s Jeffrey Keller at Aging2.0 Launch


LSU Pennington Biomedical Research Center
6400 Perkins Road, Baton Rouge, LA 70808